

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.28528211 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 5.28528211 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.21312047 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.21312047 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.12173850 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.05619909 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 5.05619909 |
| 8 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.00595152 |
| 9 | glyoxylate metabolic process (GO:0046487) | 4.86942248 |
| 10 | respiratory electron transport chain (GO:0022904) | 4.60804338 |
| 11 | cysteine metabolic process (GO:0006534) | 4.51793647 |
| 12 | electron transport chain (GO:0022900) | 4.48522139 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.27674422 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.27133126 |
| 15 | fatty acid beta-oxidation (GO:0006635) | 4.19387031 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.19026212 |
| 17 | cytidine metabolic process (GO:0046087) | 4.18237444 |
| 18 | cytidine catabolic process (GO:0006216) | 4.18237444 |
| 19 | cytidine deamination (GO:0009972) | 4.18237444 |
| 20 | lysine catabolic process (GO:0006554) | 4.12718975 |
| 21 | lysine metabolic process (GO:0006553) | 4.12718975 |
| 22 | branched-chain amino acid catabolic process (GO:0009083) | 4.08726826 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.03485022 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.99470638 |
| 25 | negative regulation of cell killing (GO:0031342) | 3.98875271 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.98875271 |
| 27 | short-chain fatty acid metabolic process (GO:0046459) | 3.95902205 |
| 28 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.92792642 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.91879655 |
| 30 | branched-chain amino acid metabolic process (GO:0009081) | 3.87728994 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.85053432 |
| 32 | fatty acid catabolic process (GO:0009062) | 3.84938169 |
| 33 | aldehyde catabolic process (GO:0046185) | 3.84363075 |
| 34 | fatty acid oxidation (GO:0019395) | 3.78703874 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.77618516 |
| 36 | nucleoside diphosphate catabolic process (GO:0009134) | 3.74465910 |
| 37 | acetyl-CoA metabolic process (GO:0006084) | 3.73430811 |
| 38 | bile acid biosynthetic process (GO:0006699) | 3.73226928 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 3.72737291 |
| 40 | lipid oxidation (GO:0034440) | 3.71900002 |
| 41 | proline metabolic process (GO:0006560) | 3.69956144 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.65633912 |
| 43 | valine metabolic process (GO:0006573) | 3.63395375 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 3.63172990 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62697986 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 3.52751925 |
| 47 | ethanol oxidation (GO:0006069) | 3.52170764 |
| 48 | monocarboxylic acid catabolic process (GO:0072329) | 3.50773574 |
| 49 | positive T cell selection (GO:0043368) | 3.48657726 |
| 50 | 2-oxoglutarate metabolic process (GO:0006103) | 3.45230826 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 3.44021553 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.43250717 |
| 53 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.40411367 |
| 54 | drug transmembrane transport (GO:0006855) | 3.40084914 |
| 55 | DNA deamination (GO:0045006) | 3.40030971 |
| 56 | T cell migration (GO:0072678) | 3.39906159 |
| 57 | glutathione biosynthetic process (GO:0006750) | 3.39702306 |
| 58 | tryptophan catabolic process (GO:0006569) | 3.37277758 |
| 59 | indole-containing compound catabolic process (GO:0042436) | 3.37277758 |
| 60 | indolalkylamine catabolic process (GO:0046218) | 3.37277758 |
| 61 | response to mercury ion (GO:0046689) | 3.33076318 |
| 62 | oxidative phosphorylation (GO:0006119) | 3.30017862 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.29462922 |
| 64 | negative T cell selection (GO:0043383) | 3.29350914 |
| 65 | carboxylic acid catabolic process (GO:0046395) | 3.29287770 |
| 66 | organic acid catabolic process (GO:0016054) | 3.29287770 |
| 67 | cellular amino acid catabolic process (GO:0009063) | 3.28609253 |
| 68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28268789 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 3.27726924 |
| 70 | kynurenine metabolic process (GO:0070189) | 3.27639790 |
| 71 | heme transport (GO:0015886) | 3.26097096 |
| 72 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.24288508 |
| 73 | carnitine metabolic process (GO:0009437) | 3.24210406 |
| 74 | thymic T cell selection (GO:0045061) | 3.23747012 |
| 75 | tryptophan metabolic process (GO:0006568) | 3.23162569 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.19550871 |
| 77 | creatine metabolic process (GO:0006600) | 3.17373315 |
| 78 | negative thymic T cell selection (GO:0045060) | 3.14661767 |
| 79 | serine family amino acid catabolic process (GO:0009071) | 3.13140205 |
| 80 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.12825768 |
| 81 | alpha-linolenic acid metabolic process (GO:0036109) | 3.09845256 |
| 82 | coenzyme catabolic process (GO:0009109) | 3.09820557 |
| 83 | chaperone-mediated protein transport (GO:0072321) | 3.09092590 |
| 84 | serine family amino acid biosynthetic process (GO:0009070) | 3.08114265 |
| 85 | biotin metabolic process (GO:0006768) | 3.07368835 |
| 86 | ketone body metabolic process (GO:1902224) | 3.06076472 |
| 87 | ATP biosynthetic process (GO:0006754) | 3.05596475 |
| 88 | glutathione metabolic process (GO:0006749) | 3.05585965 |
| 89 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.05567634 |
| 90 | tyrosine metabolic process (GO:0006570) | 3.05528781 |
| 91 | urate metabolic process (GO:0046415) | 3.05334579 |
| 92 | NADH metabolic process (GO:0006734) | 3.02794111 |
| 93 | T cell selection (GO:0045058) | 3.02324293 |
| 94 | alkaloid metabolic process (GO:0009820) | 3.02127655 |
| 95 | regulation of oxidative phosphorylation (GO:0002082) | 3.01479132 |
| 96 | bile acid metabolic process (GO:0008206) | 3.00793886 |
| 97 | cellular response to interleukin-15 (GO:0071350) | 2.97799358 |
| 98 | regulation of regulatory T cell differentiation (GO:0045589) | 2.96773996 |
| 99 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.91976870 |
| 100 | glutathione derivative biosynthetic process (GO:1901687) | 2.91178537 |
| 101 | glutathione derivative metabolic process (GO:1901685) | 2.91178537 |
| 102 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.90114297 |
| 103 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.88944269 |
| 104 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.88944269 |
| 105 | thioester metabolic process (GO:0035383) | 2.88094319 |
| 106 | acyl-CoA metabolic process (GO:0006637) | 2.88094319 |
| 107 | drug transport (GO:0015893) | 2.87514047 |
| 108 | small molecule catabolic process (GO:0044282) | 2.86031062 |
| 109 | cofactor catabolic process (GO:0051187) | 2.85981332 |
| 110 | tricarboxylic acid cycle (GO:0006099) | 2.85004346 |
| 111 | homocysteine metabolic process (GO:0050667) | 2.85003300 |
| 112 | T cell costimulation (GO:0031295) | 2.84626205 |
| 113 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.84599047 |
| 114 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.83980509 |
| 115 | succinate metabolic process (GO:0006105) | 2.83538207 |
| 116 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.82986885 |
| 117 | NADP metabolic process (GO:0006739) | 2.81741607 |
| 118 | pentose metabolic process (GO:0019321) | 2.81668369 |
| 119 | lymphocyte costimulation (GO:0031294) | 2.81635218 |
| 120 | regulation of triglyceride catabolic process (GO:0010896) | 2.81272155 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81145347 |
| 122 | tricarboxylic acid metabolic process (GO:0072350) | 2.81112938 |
| 123 | ribonucleoside diphosphate metabolic process (GO:0009185) | 2.80004852 |
| 124 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.79137784 |
| 125 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.79055454 |
| 126 | NAD biosynthetic process (GO:0009435) | 2.78861707 |
| 127 | NAD metabolic process (GO:0019674) | 2.78374176 |
| 128 | peptide biosynthetic process (GO:0043043) | 2.78271865 |
| 129 | regulation of antigen processing and presentation (GO:0002577) | 2.77521278 |
| 130 | benzene-containing compound metabolic process (GO:0042537) | 2.76958188 |
| 131 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.75742829 |
| 132 | cellular modified amino acid catabolic process (GO:0042219) | 2.75450215 |
| 133 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75076838 |
| 134 | heme biosynthetic process (GO:0006783) | 2.74971722 |
| 135 | indolalkylamine metabolic process (GO:0006586) | 2.74851218 |
| 136 | glutamate metabolic process (GO:0006536) | 2.73950230 |
| 137 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.73836510 |
| 138 | oxygen transport (GO:0015671) | 2.73704243 |
| 139 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.72658803 |
| 140 | B cell mediated immunity (GO:0019724) | 2.71170821 |
| 141 | regulation of relaxation of muscle (GO:1901077) | 2.70000366 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66989074 |
| 143 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.66711635 |
| 144 | NIK/NF-kappaB signaling (GO:0038061) | 2.66257280 |
| 145 | regulation of germinal center formation (GO:0002634) | 2.65777426 |
| 146 | response to interleukin-15 (GO:0070672) | 2.65428590 |
| 147 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63791380 |
| 148 | muscle filament sliding (GO:0030049) | 2.62751091 |
| 149 | actin-myosin filament sliding (GO:0033275) | 2.62751091 |
| 150 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.62418286 |
| 151 | neutrophil activation involved in immune response (GO:0002283) | 2.60439113 |
| 152 | T cell receptor signaling pathway (GO:0050852) | 2.58446444 |
| 153 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.54527214 |
| 154 | actin nucleation (GO:0045010) | 2.54413899 |
| 155 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.54409288 |
| 156 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.54258203 |
| 157 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.54258203 |
| 158 | positive regulation of B cell differentiation (GO:0045579) | 2.53136634 |
| 159 | lymphocyte chemotaxis (GO:0048247) | 2.52037634 |
| 160 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.50483708 |
| 161 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.50483708 |
| 162 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.50393369 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.50197549 |
| 164 | positive regulation of interleukin-4 production (GO:0032753) | 2.47760750 |
| 165 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.46686583 |
| 166 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.46569661 |
| 167 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.45903714 |
| 168 | regulation of interleukin-4 production (GO:0032673) | 2.43891462 |
| 169 | granulocyte activation (GO:0036230) | 2.43155814 |
| 170 | positive regulation of lymphocyte migration (GO:2000403) | 2.43149306 |
| 171 | gas transport (GO:0015669) | 2.42631488 |
| 172 | tolerance induction (GO:0002507) | 2.42022315 |
| 173 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.42018070 |
| 174 | regulation of cell communication by electrical coupling (GO:0010649) | 2.41478939 |
| 175 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.40701760 |
| 176 | regulation of B cell differentiation (GO:0045577) | 2.40542905 |
| 177 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.40021473 |
| 178 | negative regulation of T cell apoptotic process (GO:0070233) | 2.39018452 |
| 179 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.38822607 |
| 180 | mature B cell differentiation involved in immune response (GO:0002313) | 2.37655208 |
| 181 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.37589178 |
| 182 | mast cell activation (GO:0045576) | 2.37347910 |
| 183 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.36586930 |
| 184 | detection of bacterium (GO:0016045) | 2.35402061 |
| 185 | cellular response to type I interferon (GO:0071357) | 2.33068822 |
| 186 | type I interferon signaling pathway (GO:0060337) | 2.33068822 |
| 187 | B cell homeostasis (GO:0001782) | 2.32305227 |
| 188 | defense response to protozoan (GO:0042832) | 2.32280905 |
| 189 | regulation of platelet aggregation (GO:0090330) | 2.31821933 |
| 190 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.31440033 |
| 191 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.30670892 |
| 192 | positive regulation of antigen processing and presentation (GO:0002579) | 2.30187942 |
| 193 | regulation of lymphocyte migration (GO:2000401) | 2.30011910 |
| 194 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.28973738 |
| 195 | response to type I interferon (GO:0034340) | 2.26898076 |
| 196 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.26815728 |
| 197 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.26026999 |
| 198 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.24897990 |
| 199 | lymphocyte migration (GO:0072676) | 2.24847590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.63453055 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.55874063 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.70306402 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.90146390 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.38091776 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.75149579 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.38091931 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.34897169 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.31471121 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.22001329 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.20298413 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.18779654 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.14101349 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.89215784 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.86726907 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.77727058 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.76271222 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.76155817 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.71268363 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.70524368 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.61872457 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.43988208 |
| 23 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.42935960 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42712040 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.29702152 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 2.24196211 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19010993 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.18885742 |
| 29 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.18175205 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07407529 |
| 31 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06428717 |
| 32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.06035260 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.05025952 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.95489188 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.92322119 |
| 36 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92001632 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91752783 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.91730574 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86373041 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.85914014 |
| 41 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.80339837 |
| 42 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78062866 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77505029 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77135159 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75478873 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.74792215 |
| 47 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.74416357 |
| 48 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.73228933 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.71042732 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.66263649 |
| 51 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.64459408 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64171522 |
| 53 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58719753 |
| 54 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.56916856 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56622955 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.55476228 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53543779 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52602215 |
| 59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52378365 |
| 60 | * MYB_26560356_Chip-Seq_TH1_Human | 1.51979277 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51737897 |
| 62 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51471081 |
| 63 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.47950631 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46488391 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46203609 |
| 66 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.42641678 |
| 67 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40177059 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40058480 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36616247 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35893152 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35166629 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35067063 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32986354 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32746283 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31761864 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30386365 |
| 77 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29760872 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28969682 |
| 79 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.27817138 |
| 80 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27505269 |
| 81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.27277961 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25506444 |
| 83 | MYC_22102868_ChIP-Seq_BL_Human | 1.25401892 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24492038 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23262278 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.22880700 |
| 87 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22074854 |
| 88 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20791653 |
| 89 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.20776723 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20415242 |
| 91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20253921 |
| 92 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19619794 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19492267 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19287160 |
| 95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18381398 |
| 96 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.15685504 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15561268 |
| 98 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14773524 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14363048 |
| 100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13221749 |
| 101 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12703738 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12652473 |
| 103 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.10351418 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09307358 |
| 105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08467763 |
| 106 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.07472180 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06476823 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05386000 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04705583 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04428523 |
| 111 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01671956 |
| 112 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01519984 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01245291 |
| 114 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.00688076 |
| 115 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.00292863 |
| 116 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99500034 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98910708 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98328337 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98256654 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97846221 |
| 121 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96391142 |
| 122 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96336735 |
| 123 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96202100 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95940742 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95093526 |
| 126 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94757584 |
| 127 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94309682 |
| 128 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93721662 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92930016 |
| 130 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 0.92771808 |
| 131 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.90630433 |
| 132 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.90434429 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90187676 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89567540 |
| 135 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89551694 |
| 136 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88670357 |
| 137 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88616224 |
| 138 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88586619 |
| 139 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88452508 |
| 140 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88422327 |
| 141 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87931848 |
| 142 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.87657967 |
| 143 | P300_27268052_Chip-Seq_Bcells_Human | 0.87140916 |
| 144 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86884617 |
| 145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86736639 |
| 146 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86568159 |
| 147 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.86566510 |
| 148 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86496388 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86441990 |
| 150 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86352902 |
| 151 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83651084 |
| 152 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.82634722 |
| 153 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82201328 |
| 154 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.82198612 |
| 155 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.80886550 |
| 156 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.80413529 |
| 157 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79974425 |
| 158 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.79440799 |
| 159 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78286928 |
| 160 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77689276 |
| 161 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77042126 |
| 162 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76777440 |
| 163 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76164821 |
| 164 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75554935 |
| 165 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.75548975 |
| 166 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75528048 |
| 167 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.75464429 |
| 168 | P68_20966046_ChIP-Seq_HELA_Human | 0.75445405 |
| 169 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.75099869 |
| 170 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74350970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.22115494 |
| 2 | MP0005360_urolithiasis | 4.72088227 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.60793326 |
| 4 | MP0005365_abnormal_bile_salt | 3.98764041 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.88752209 |
| 6 | MP0005671_abnormal_response_to | 3.71130736 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.50295537 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.17722449 |
| 9 | MP0005332_abnormal_amino_acid | 3.03919485 |
| 10 | MP0003195_calcinosis | 2.96378241 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.70842780 |
| 12 | MP0000685_abnormal_immune_system | 2.70137357 |
| 13 | MP0005083_abnormal_biliary_tract | 2.65230909 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.64934278 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.63664667 |
| 16 | MP0009840_abnormal_foam_cell | 2.63556270 |
| 17 | MP0005387_immune_system_phenotype | 2.62750551 |
| 18 | MP0001790_abnormal_immune_system | 2.62750551 |
| 19 | MP0003186_abnormal_redox_activity | 2.58629832 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.53633508 |
| 21 | MP0001800_abnormal_humoral_immune | 2.49382582 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.43679020 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.36457754 |
| 24 | MP0009785_altered_susceptibility_to | 2.28936294 |
| 25 | MP0001986_abnormal_taste_sensitivity | 2.28753900 |
| 26 | MP0003436_decreased_susceptibility_to | 2.28032303 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.19020478 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 2.18317258 |
| 29 | MP0002723_abnormal_immune_serum | 2.17341374 |
| 30 | MP0003303_peritoneal_inflammation | 2.16351617 |
| 31 | MP0005025_abnormal_response_to | 2.07812068 |
| 32 | MP0009643_abnormal_urine_homeostasis | 2.07180508 |
| 33 | MP0002420_abnormal_adaptive_immunity | 2.06406231 |
| 34 | MP0001819_abnormal_immune_cell | 2.02866641 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 2.00789472 |
| 36 | MP0005451_abnormal_body_composition | 2.00760543 |
| 37 | MP0010329_abnormal_lipoprotein_level | 2.00059059 |
| 38 | MP0002452_abnormal_antigen_presenting | 2.00049552 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.96475500 |
| 40 | MP0004510_myositis | 1.96466042 |
| 41 | MP0003646_muscle_fatigue | 1.89056823 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.86501508 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.85094298 |
| 44 | MP0003252_abnormal_bile_duct | 1.84448148 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.82134109 |
| 46 | MP0004043_abnormal_pH_regulation | 1.80614084 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.79164126 |
| 48 | MP0006082_CNS_inflammation | 1.73179982 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.72174257 |
| 50 | MP0005636_abnormal_mineral_homeostasis | 1.72091586 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.71428535 |
| 52 | MP0002419_abnormal_innate_immunity | 1.69519106 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.66437662 |
| 54 | MP0002398_abnormal_bone_marrow | 1.64722993 |
| 55 | MP0005670_abnormal_white_adipose | 1.62455401 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.61034234 |
| 57 | MP0000716_abnormal_immune_system | 1.57388320 |
| 58 | MP0003866_abnormal_defecation | 1.54250247 |
| 59 | MP0004130_abnormal_muscle_cell | 1.52132195 |
| 60 | MP0005330_cardiomyopathy | 1.50607670 |
| 61 | MP0000609_abnormal_liver_physiology | 1.49995218 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.48123190 |
| 63 | MP0005535_abnormal_body_temperature | 1.46123319 |
| 64 | MP0004084_abnormal_cardiac_muscle | 1.42295853 |
| 65 | MP0001756_abnormal_urination | 1.41180290 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.40314912 |
| 67 | MP0009379_abnormal_foot_pigmentation | 1.39532484 |
| 68 | MP0001764_abnormal_homeostasis | 1.38620077 |
| 69 | MP0000920_abnormal_myelination | 1.36157533 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.36023201 |
| 71 | MP0003724_increased_susceptibility_to | 1.35549778 |
| 72 | MP0001765_abnormal_ion_homeostasis | 1.33405237 |
| 73 | MP0004147_increased_porphyrin_level | 1.31713425 |
| 74 | MP0005423_abnormal_somatic_nervous | 1.26851099 |
| 75 | MP0003329_amyloid_beta_deposits | 1.26729273 |
| 76 | MP0002429_abnormal_blood_cell | 1.26263799 |
| 77 | MP0003172_abnormal_lysosome_physiology | 1.25578300 |
| 78 | MP0002166_altered_tumor_susceptibility | 1.25310308 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.24055811 |
| 80 | MP0004484_altered_response_of | 1.23707864 |
| 81 | MP0002722_abnormal_immune_system | 1.22478143 |
| 82 | MP0003879_abnormal_hair_cell | 1.21919994 |
| 83 | MP0001905_abnormal_dopamine_level | 1.18981031 |
| 84 | MP0001533_abnormal_skeleton_physiology | 1.18014851 |
| 85 | MP0002405_respiratory_system_inflammati | 1.17737209 |
| 86 | MP0004142_abnormal_muscle_tone | 1.16446736 |
| 87 | MP0001661_extended_life_span | 1.15520277 |
| 88 | MP0000749_muscle_degeneration | 1.14662007 |
| 89 | MP0002972_abnormal_cardiac_muscle | 1.14621315 |
| 90 | MP0000747_muscle_weakness | 1.14428040 |
| 91 | MP0000751_myopathy | 1.12326314 |
| 92 | MP0003183_abnormal_peptide_metabolism | 1.11999138 |
| 93 | MP0004215_abnormal_myocardial_fiber | 1.11634238 |
| 94 | MP0006276_abnormal_autonomic_nervous | 1.11186159 |
| 95 | MP0004947_skin_inflammation | 1.09782330 |
| 96 | MP0005058_abnormal_lysosome_morphology | 1.09496366 |
| 97 | MP0008004_abnormal_stomach_pH | 1.09328765 |
| 98 | MP0005165_increased_susceptibility_to | 1.07463980 |
| 99 | MP0005166_decreased_susceptibility_to | 1.05981455 |
| 100 | MP0000230_abnormal_systemic_arterial | 1.05151449 |
| 101 | MP0004859_abnormal_synaptic_plasticity | 1.04877447 |
| 102 | MP0000604_amyloidosis | 1.03770507 |
| 103 | MP0008569_lethality_at_weaning | 1.02834734 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.99158039 |
| 105 | MP0008469_abnormal_protein_level | 0.98945257 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.98689160 |
| 107 | MP0005310_abnormal_salivary_gland | 0.97552410 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.97261090 |
| 109 | MP0005266_abnormal_metabolism | 0.95900566 |
| 110 | MP0002132_abnormal_respiratory_system | 0.95677688 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.95538611 |
| 112 | MP0003045_fibrosis | 0.95121319 |
| 113 | MP0001873_stomach_inflammation | 0.92577883 |
| 114 | MP0002971_abnormal_brown_adipose | 0.92099456 |
| 115 | MP0002106_abnormal_muscle_physiology | 0.90765336 |
| 116 | MP0005385_cardiovascular_system_phenoty | 0.90666768 |
| 117 | MP0001544_abnormal_cardiovascular_syste | 0.90666768 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.89581707 |
| 119 | MP0003075_altered_response_to | 0.89302054 |
| 120 | MP0003638_abnormal_response/metabolism_ | 0.89132174 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.87789665 |
| 122 | MP0009764_decreased_sensitivity_to | 0.87083652 |
| 123 | MP0000343_altered_response_to | 0.85782056 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.85280326 |
| 125 | MP0005334_abnormal_fat_pad | 0.85219140 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.84788625 |
| 127 | MP0000759_abnormal_skeletal_muscle | 0.84230180 |
| 128 | MP0005379_endocrine/exocrine_gland_phen | 0.83902884 |
| 129 | MP0001727_abnormal_embryo_implantation | 0.83851531 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.83338043 |
| 131 | MP0000858_altered_metastatic_potential | 0.82989858 |
| 132 | MP0002269_muscular_atrophy | 0.82780282 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.82409217 |
| 134 | MP0004087_abnormal_muscle_fiber | 0.81644492 |
| 135 | MP0001851_eye_inflammation | 0.81148939 |
| 136 | MP0001529_abnormal_vocalization | 0.80700459 |
| 137 | MP0004036_abnormal_muscle_relaxation | 0.79795032 |
| 138 | MP0002998_abnormal_bone_remodeling | 0.78831885 |
| 139 | MP0009697_abnormal_copulation | 0.78397849 |
| 140 | MP0003300_gastrointestinal_ulcer | 0.77566736 |
| 141 | MP0002933_joint_inflammation | 0.76504029 |
| 142 | MP0001853_heart_inflammation | 0.76354320 |
| 143 | MP0001501_abnormal_sleep_pattern | 0.74905460 |
| 144 | MP0002006_tumorigenesis | 0.73903967 |
| 145 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73827894 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.73781117 |
| 147 | MP0000358_abnormal_cell_content/ | 0.73261475 |
| 148 | MP0002064_seizures | 0.72050245 |
| 149 | MP0008775_abnormal_heart_ventricle | 0.71942193 |
| 150 | MP0003868_abnormal_feces_composition | 0.71805847 |
| 151 | MP0009763_increased_sensitivity_to | 0.70292773 |
| 152 | MP0002332_abnormal_exercise_endurance | 0.69502606 |
| 153 | MP0003718_maternal_effect | 0.69309111 |
| 154 | MP0000598_abnormal_liver_morphology | 0.68614762 |
| 155 | MP0003690_abnormal_glial_cell | 0.67556333 |
| 156 | MP0005395_other_phenotype | 0.66420719 |
| 157 | MP0005408_hypopigmentation | 0.66385076 |
| 158 | MP0008874_decreased_physiological_sensi | 0.65125890 |
| 159 | MP0000750_abnormal_muscle_regeneration | 0.64127350 |
| 160 | MP0000639_abnormal_adrenal_gland | 0.63119636 |
| 161 | MP0008260_abnormal_autophagy | 0.62402933 |
| 162 | MP0002295_abnormal_pulmonary_circulatio | 0.61600353 |
| 163 | MP0003136_yellow_coat_color | 0.61507392 |
| 164 | MP0003953_abnormal_hormone_level | 0.60714641 |
| 165 | MP0005620_abnormal_muscle_contractility | 0.59727005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.40995943 |
| 2 | Acute encephalopathy (HP:0006846) | 3.98791523 |
| 3 | Hepatic necrosis (HP:0002605) | 3.90246767 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 3.71391428 |
| 5 | Hyperglycinuria (HP:0003108) | 3.64834558 |
| 6 | * Increased muscle lipid content (HP:0009058) | 3.61946397 |
| 7 | Cerebral edema (HP:0002181) | 3.60969226 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.57725187 |
| 9 | Lipid accumulation in hepatocytes (HP:0006561) | 3.57599263 |
| 10 | * Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.55310742 |
| 11 | * Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.55310742 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.51752720 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.48789562 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.48753509 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.47628981 |
| 16 | * Increased intramyocellular lipid droplets (HP:0012240) | 3.44884393 |
| 17 | Generalized aminoaciduria (HP:0002909) | 3.38049480 |
| 18 | Increased hepatocellular lipid droplets (HP:0006565) | 3.37564687 |
| 19 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.34901424 |
| 20 | Dicarboxylic aciduria (HP:0003215) | 3.34901424 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 3.32215519 |
| 22 | Ketosis (HP:0001946) | 3.31967147 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.31566191 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.31566191 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.31052860 |
| 26 | Hyperammonemia (HP:0001987) | 3.21640936 |
| 27 | Nemaline bodies (HP:0003798) | 3.20886149 |
| 28 | Exercise-induced myalgia (HP:0003738) | 3.18901610 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.18197986 |
| 30 | Muscle fiber inclusion bodies (HP:0100299) | 3.18049746 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 3.13102481 |
| 32 | Glycosuria (HP:0003076) | 3.13102481 |
| 33 | Ketoacidosis (HP:0001993) | 3.10196079 |
| 34 | Bundle branch block (HP:0011710) | 3.09180777 |
| 35 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.09102498 |
| 36 | Lethargy (HP:0001254) | 3.07237408 |
| 37 | * Lactic acidosis (HP:0003128) | 3.03428296 |
| 38 | * Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.02567925 |
| 39 | Increased CSF lactate (HP:0002490) | 3.00566435 |
| 40 | Proximal tubulopathy (HP:0000114) | 2.99892372 |
| 41 | T lymphocytopenia (HP:0005403) | 2.98940523 |
| 42 | Stomatitis (HP:0010280) | 2.98162423 |
| 43 | Gastrointestinal stroma tumor (HP:0100723) | 2.93924713 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 2.92479487 |
| 45 | Progressive macrocephaly (HP:0004481) | 2.91517643 |
| 46 | Large for gestational age (HP:0001520) | 2.91381980 |
| 47 | Hyperglycinemia (HP:0002154) | 2.91095022 |
| 48 | Xanthomatosis (HP:0000991) | 2.89790725 |
| 49 | Gout (HP:0001997) | 2.86078923 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.85691963 |
| 51 | Sudden death (HP:0001699) | 2.83745981 |
| 52 | Meningitis (HP:0001287) | 2.83568747 |
| 53 | Delayed CNS myelination (HP:0002188) | 2.79319606 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.78291710 |
| 55 | Eczematoid dermatitis (HP:0000976) | 2.77815987 |
| 56 | Purpura (HP:0000979) | 2.73583808 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.73101742 |
| 58 | Long foot (HP:0001833) | 2.72191529 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72182320 |
| 60 | Obstructive lung disease (HP:0006536) | 2.72182320 |
| 61 | Hyporeflexia of lower limbs (HP:0002600) | 2.70007519 |
| 62 | Asymmetric septal hypertrophy (HP:0001670) | 2.67270318 |
| 63 | IgG deficiency (HP:0004315) | 2.65671783 |
| 64 | Vomiting (HP:0002013) | 2.65370057 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.64035862 |
| 66 | Petechiae (HP:0000967) | 2.63784426 |
| 67 | Increased IgM level (HP:0003496) | 2.62226412 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.60935042 |
| 69 | Type 1 muscle fiber predominance (HP:0003803) | 2.59490571 |
| 70 | Distal lower limb muscle weakness (HP:0009053) | 2.59317195 |
| 71 | Respiratory failure (HP:0002878) | 2.59117496 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58937451 |
| 73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.55795884 |
| 74 | Metabolic acidosis (HP:0001942) | 2.55315435 |
| 75 | Exertional dyspnea (HP:0002875) | 2.53502737 |
| 76 | Deep venous thrombosis (HP:0002625) | 2.53216998 |
| 77 | 3-Methylglutaconic aciduria (HP:0003535) | 2.52844371 |
| 78 | Hyperlipoproteinemia (HP:0010980) | 2.51573742 |
| 79 | Recurrent bronchitis (HP:0002837) | 2.51557581 |
| 80 | Hyperphosphaturia (HP:0003109) | 2.51079598 |
| 81 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.50934063 |
| 82 | Abnormality of renal resorption (HP:0011038) | 2.49116906 |
| 83 | Vasculitis (HP:0002633) | 2.48033308 |
| 84 | Chest pain (HP:0100749) | 2.46827724 |
| 85 | EMG: myopathic abnormalities (HP:0003458) | 2.44771633 |
| 86 | Epistaxis (HP:0000421) | 2.44477211 |
| 87 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.43594693 |
| 88 | * Exercise intolerance (HP:0003546) | 2.42363434 |
| 89 | Nausea (HP:0002018) | 2.42144188 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 2.38911676 |
| 91 | * Increased serum lactate (HP:0002151) | 2.37427360 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.36041243 |
| 93 | Recurrent bacterial skin infections (HP:0005406) | 2.34649476 |
| 94 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.33111444 |
| 95 | Increased serum pyruvate (HP:0003542) | 2.32084055 |
| 96 | Abnormality of glycolysis (HP:0004366) | 2.32084055 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.31932171 |
| 98 | Renal salt wasting (HP:0000127) | 2.31674452 |
| 99 | Spastic paraparesis (HP:0002313) | 2.30588400 |
| 100 | Chronic diarrhea (HP:0002028) | 2.30255267 |
| 101 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.30168231 |
| 102 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.30028750 |
| 103 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29795425 |
| 104 | * Myoglobinuria (HP:0002913) | 2.29394049 |
| 105 | Recurrent abscess formation (HP:0002722) | 2.28240719 |
| 106 | Prolonged partial thromboplastin time (HP:0003645) | 2.27757357 |
| 107 | Recurrent sinusitis (HP:0011108) | 2.27610783 |
| 108 | Increased circulating renin level (HP:0000848) | 2.26976857 |
| 109 | Leukodystrophy (HP:0002415) | 2.26508597 |
| 110 | Alkalosis (HP:0001948) | 2.24095128 |
| 111 | Ragged-red muscle fibers (HP:0003200) | 2.23391376 |
| 112 | Cellulitis (HP:0100658) | 2.23359169 |
| 113 | Cerebral hemorrhage (HP:0001342) | 2.22430631 |
| 114 | Recurrent fungal infections (HP:0002841) | 2.21171527 |
| 115 | Abnormality of T cells (HP:0002843) | 2.20927899 |
| 116 | Pulmonary infiltrates (HP:0002113) | 2.20599966 |
| 117 | Methylmalonic aciduria (HP:0012120) | 2.20538053 |
| 118 | Hypobetalipoproteinemia (HP:0003563) | 2.20448934 |
| 119 | Hypokalemic alkalosis (HP:0001949) | 2.20004205 |
| 120 | Abnormal urine phosphate concentration (HP:0012599) | 2.19851509 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18798626 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18798626 |
| 123 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18798626 |
| 124 | Abnormality of serum amino acid levels (HP:0003112) | 2.18531281 |
| 125 | Hypomagnesemia (HP:0002917) | 2.18333532 |
| 126 | Heart block (HP:0012722) | 2.18144100 |
| 127 | Duplicated collecting system (HP:0000081) | 2.17862680 |
| 128 | Increased variability in muscle fiber diameter (HP:0003557) | 2.17466947 |
| 129 | Increased purine levels (HP:0004368) | 2.16511865 |
| 130 | Hyperuricemia (HP:0002149) | 2.16511865 |
| 131 | Myositis (HP:0100614) | 2.16134807 |
| 132 | Lymphopenia (HP:0001888) | 2.15904978 |
| 133 | Neuroendocrine neoplasm (HP:0100634) | 2.15870422 |
| 134 | Abnormality of magnesium homeostasis (HP:0004921) | 2.15684648 |
| 135 | Neck muscle weakness (HP:0000467) | 2.13914423 |
| 136 | Inflammation of the large intestine (HP:0002037) | 2.13415196 |
| 137 | Progressive external ophthalmoplegia (HP:0000590) | 2.12263075 |
| 138 | Dysostosis multiplex (HP:0000943) | 2.11773083 |
| 139 | Pustule (HP:0200039) | 2.11676117 |
| 140 | IgM deficiency (HP:0002850) | 2.09482059 |
| 141 | Encephalitis (HP:0002383) | 2.08540848 |
| 142 | CNS demyelination (HP:0007305) | 2.08020150 |
| 143 | Pheochromocytoma (HP:0002666) | 2.06288591 |
| 144 | Gingival bleeding (HP:0000225) | 2.06170585 |
| 145 | Hyperbilirubinemia (HP:0002904) | 2.05984671 |
| 146 | Complement deficiency (HP:0004431) | 2.05980398 |
| 147 | Abnormality of binocular vision (HP:0011514) | 2.05181310 |
| 148 | Diplopia (HP:0000651) | 2.05181310 |
| 149 | Abnormal atrioventricular conduction (HP:0005150) | 2.05128294 |
| 150 | Verrucae (HP:0200043) | 2.03991828 |
| 151 | Papilloma (HP:0012740) | 2.03991828 |
| 152 | * Rhabdomyolysis (HP:0003201) | 2.03950910 |
| 153 | Spontaneous hematomas (HP:0007420) | 2.03105353 |
| 154 | Muscle fiber splitting (HP:0003555) | 2.00986899 |
| 155 | Recurrent viral infections (HP:0004429) | 2.00488424 |
| 156 | Areflexia of lower limbs (HP:0002522) | 1.98712290 |
| 157 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.97856284 |
| 158 | Recurrent cutaneous fungal infections (HP:0011370) | 1.97856284 |
| 159 | Joint swelling (HP:0001386) | 1.97846472 |
| 160 | Gastrointestinal inflammation (HP:0004386) | 1.97675508 |
| 161 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96105407 |
| 162 | Visual hallucinations (HP:0002367) | 1.94848607 |
| 163 | Ventricular tachycardia (HP:0004756) | 1.94120534 |
| 164 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94021590 |
| 165 | Hepatosplenomegaly (HP:0001433) | 1.93428633 |
| 166 | Ventricular fibrillation (HP:0001663) | 1.92935732 |
| 167 | Metabolic alkalosis (HP:0200114) | 1.91995902 |
| 168 | Hemorrhage of the eye (HP:0011885) | 1.91168504 |
| 169 | Axonal loss (HP:0003447) | 1.91126183 |
| 170 | Restrictive lung disease (HP:0002091) | 1.91096549 |
| 171 | Colitis (HP:0002583) | 1.91006714 |
| 172 | Papilledema (HP:0001085) | 1.90358014 |
| 173 | Myopathic facies (HP:0002058) | 1.89686827 |
| 174 | Ventricular arrhythmia (HP:0004308) | 1.89572351 |
| 175 | Oligomenorrhea (HP:0000876) | 1.89475794 |
| 176 | Urticaria (HP:0001025) | 1.89255220 |
| 177 | Hyperaldosteronism (HP:0000859) | 1.88774358 |
| 178 | Late onset (HP:0003584) | 1.88377507 |
| 179 | Pancreatitis (HP:0001733) | 1.87800268 |
| 180 | Acute hepatic failure (HP:0006554) | 1.87391546 |
| 181 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87198548 |
| 182 | Vacuolated lymphocytes (HP:0001922) | 1.87084026 |
| 183 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.86965285 |
| 184 | Myokymia (HP:0002411) | 1.86125555 |
| 185 | Abnormality of the prostate (HP:0008775) | 1.85806604 |
| 186 | Progressive muscle weakness (HP:0003323) | 1.85802892 |
| 187 | Recurrent skin infections (HP:0001581) | 1.84390329 |
| 188 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.83587070 |
| 189 | Hyperactive renin-angiotensin system (HP:0000841) | 1.83517735 |
| 190 | Fat malabsorption (HP:0002630) | 1.83248157 |
| 191 | Neonatal onset (HP:0003623) | 1.83226116 |
| 192 | Subaortic stenosis (HP:0001682) | 1.82809636 |
| 193 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.82809636 |
| 194 | Systemic lupus erythematosus (HP:0002725) | 1.81907291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.08157323 |
| 2 | NME2 | 3.70563527 |
| 3 | RIPK4 | 3.67448561 |
| 4 | MAP4K1 | 3.10061975 |
| 5 | TXK | 3.05658618 |
| 6 | WNK4 | 2.80991538 |
| 7 | STK16 | 2.64962300 |
| 8 | MAPK15 | 2.60612466 |
| 9 | PINK1 | 2.41049151 |
| 10 | IRAK3 | 2.40487101 |
| 11 | OXSR1 | 2.27381854 |
| 12 | STK39 | 2.20045282 |
| 13 | ARAF | 2.15493998 |
| 14 | MAPKAPK3 | 2.11346402 |
| 15 | IRAK1 | 2.10391768 |
| 16 | WNK3 | 2.00899574 |
| 17 | SCYL2 | 1.97403635 |
| 18 | IRAK2 | 1.95145261 |
| 19 | CDC42BPA | 1.93704483 |
| 20 | SYK | 1.92659054 |
| 21 | BMPR2 | 1.90549142 |
| 22 | TESK2 | 1.81281558 |
| 23 | GRK6 | 1.80480196 |
| 24 | LIMK1 | 1.78481715 |
| 25 | KDR | 1.77342192 |
| 26 | PRPF4B | 1.73463802 |
| 27 | EIF2AK1 | 1.69694597 |
| 28 | ITK | 1.69132209 |
| 29 | TAOK3 | 1.63079530 |
| 30 | ICK | 1.62391458 |
| 31 | ABL2 | 1.61262048 |
| 32 | EPHB1 | 1.55685273 |
| 33 | IKBKE | 1.49993052 |
| 34 | TESK1 | 1.49083890 |
| 35 | PIM2 | 1.48535520 |
| 36 | MYLK | 1.47204729 |
| 37 | MAPKAPK5 | 1.45466745 |
| 38 | EIF2AK3 | 1.40907122 |
| 39 | BTK | 1.40496383 |
| 40 | MAP3K11 | 1.33597982 |
| 41 | GRK5 | 1.33188837 |
| 42 | CSF1R | 1.29593687 |
| 43 | TIE1 | 1.27920853 |
| 44 | ZAP70 | 1.25576675 |
| 45 | LMTK2 | 1.23813851 |
| 46 | CAMKK2 | 1.23335069 |
| 47 | PHKG2 | 1.22516544 |
| 48 | PHKG1 | 1.22516544 |
| 49 | ERN1 | 1.20653114 |
| 50 | CDK19 | 1.17514274 |
| 51 | MAP3K12 | 1.13056602 |
| 52 | PDK3 | 1.11461941 |
| 53 | PDK4 | 1.11461941 |
| 54 | DAPK2 | 1.11291878 |
| 55 | CAMKK1 | 1.09835604 |
| 56 | TEC | 1.08924086 |
| 57 | JAK1 | 1.07915085 |
| 58 | PKN1 | 1.07682614 |
| 59 | IKBKB | 1.07327169 |
| 60 | MAP3K14 | 1.06248807 |
| 61 | MAP2K2 | 1.05800999 |
| 62 | CSNK1G3 | 1.04012387 |
| 63 | PDK2 | 1.03976661 |
| 64 | MAP3K5 | 1.02349302 |
| 65 | JAK3 | 0.99590086 |
| 66 | ROCK2 | 0.99349997 |
| 67 | LYN | 0.98768097 |
| 68 | MAP3K1 | 0.97441600 |
| 69 | INSRR | 0.96668270 |
| 70 | KIT | 0.95544754 |
| 71 | CAMK2G | 0.94931148 |
| 72 | LCK | 0.94873565 |
| 73 | BLK | 0.93514054 |
| 74 | VRK1 | 0.93196117 |
| 75 | HCK | 0.93017911 |
| 76 | UHMK1 | 0.87245132 |
| 77 | NME1 | 0.84838113 |
| 78 | RPS6KA5 | 0.82664529 |
| 79 | PDK1 | 0.80474246 |
| 80 | MUSK | 0.80042096 |
| 81 | PIK3CG | 0.78975880 |
| 82 | BUB1 | 0.77753483 |
| 83 | FGFR4 | 0.76657188 |
| 84 | SIK3 | 0.76655256 |
| 85 | CAMK2D | 0.76038868 |
| 86 | JAK2 | 0.75563357 |
| 87 | DAPK1 | 0.74442799 |
| 88 | OBSCN | 0.74224437 |
| 89 | SIK2 | 0.73602314 |
| 90 | DYRK2 | 0.71292251 |
| 91 | CSNK1G1 | 0.70293080 |
| 92 | TNK2 | 0.69782221 |
| 93 | NTRK1 | 0.68962527 |
| 94 | PIM1 | 0.68343460 |
| 95 | PAK6 | 0.67578621 |
| 96 | MAP2K3 | 0.67149906 |
| 97 | TAOK2 | 0.66720744 |
| 98 | DAPK3 | 0.63527432 |
| 99 | PAK3 | 0.61854678 |
| 100 | CAMK1 | 0.61610715 |
| 101 | TLK1 | 0.61358496 |
| 102 | DYRK1B | 0.60296638 |
| 103 | MARK3 | 0.58529026 |
| 104 | FGR | 0.56656082 |
| 105 | FYN | 0.55886567 |
| 106 | ROCK1 | 0.55349485 |
| 107 | DYRK3 | 0.55083889 |
| 108 | PDPK1 | 0.55082070 |
| 109 | MST4 | 0.54909881 |
| 110 | IRAK4 | 0.51935949 |
| 111 | FLT3 | 0.51795429 |
| 112 | MAPK7 | 0.51516475 |
| 113 | PRKD2 | 0.50998862 |
| 114 | DMPK | 0.50302492 |
| 115 | TBK1 | 0.50245225 |
| 116 | PAK1 | 0.50171639 |
| 117 | MAPK4 | 0.49325319 |
| 118 | PIK3CA | 0.49305354 |
| 119 | PRKAA2 | 0.49018049 |
| 120 | MAP2K1 | 0.48762730 |
| 121 | BMX | 0.48745338 |
| 122 | TYK2 | 0.48706600 |
| 123 | CAMK2B | 0.48595884 |
| 124 | CSNK1G2 | 0.47923489 |
| 125 | PRKCD | 0.47190442 |
| 126 | FES | 0.47085448 |
| 127 | KSR2 | 0.46316048 |
| 128 | DYRK1A | 0.46302365 |
| 129 | SIK1 | 0.45677731 |
| 130 | TTN | 0.45397512 |
| 131 | ILK | 0.45317334 |
| 132 | MAPK11 | 0.44925443 |
| 133 | TRPM7 | 0.44619137 |
| 134 | MAP3K7 | 0.44485966 |
| 135 | PRKD1 | 0.44444348 |
| 136 | BCR | 0.44095827 |
| 137 | GRK7 | 0.43998558 |
| 138 | AURKA | 0.43450628 |
| 139 | PBK | 0.43382018 |
| 140 | PRKACA | 0.42496020 |
| 141 | ACVR1B | 0.42318843 |
| 142 | TRIB3 | 0.41414766 |
| 143 | EPHA4 | 0.39525564 |
| 144 | MAP2K6 | 0.39303813 |
| 145 | CAMK2A | 0.38766549 |
| 146 | MAPK12 | 0.38612009 |
| 147 | RAF1 | 0.38533823 |
| 148 | BRAF | 0.37914338 |
| 149 | PRKACG | 0.36525508 |
| 150 | CSK | 0.34966081 |
| 151 | CSNK1A1L | 0.33080309 |
| 152 | PRKCZ | 0.31708533 |
| 153 | NEK9 | 0.30435084 |
| 154 | WNK1 | 0.28760569 |
| 155 | MAP3K13 | 0.28238731 |
| 156 | PRKCQ | 0.27511816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.07189288 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.98722972 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.74764270 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.58624656 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.28222190 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.19597114 |
| 7 | Asthma_Homo sapiens_hsa05310 | 3.09705636 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.01901206 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.97587152 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.84876057 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.76580579 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.55259175 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51812020 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45647577 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42367439 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38143368 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 2.36330664 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33989322 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30914390 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24807201 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.16001244 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.11701671 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.10002247 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08995620 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.08958994 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05791469 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.02499517 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.99367447 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99127127 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.98591831 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98335355 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.96021723 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90536163 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86313118 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86068562 |
| 36 | Ribosome_Homo sapiens_hsa03010 | 1.85588532 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83163135 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.82519920 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.73972190 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71340693 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 1.64111140 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63400711 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60854167 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58188652 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57199853 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55461536 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55064722 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.54342808 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.51101352 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49087575 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46189774 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.43062770 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42354383 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.42045191 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41050970 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40180640 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33868396 |
| 58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.32214605 |
| 59 | Protein export_Homo sapiens_hsa03060 | 1.29978655 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28976490 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 1.28877672 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27754394 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26173837 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25122956 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.24144408 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20313611 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19395028 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.18202946 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.17033609 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15790802 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13036120 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12521749 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.08876586 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08469539 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07201618 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05839800 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.05482485 |
| 78 | Measles_Homo sapiens_hsa05162 | 1.02355370 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01370812 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 1.00077152 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99528203 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95428113 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95375453 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.94824059 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.93940709 |
| 86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92826089 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92084799 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90073797 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89467615 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86201703 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.86009728 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85604868 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85544657 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85017215 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84953558 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84372972 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.84350954 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81039352 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80695629 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79241908 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.75939484 |
| 102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75481336 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73249535 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.73053953 |
| 105 | RNA polymerase_Homo sapiens_hsa03020 | 0.72314827 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71000803 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.69542850 |
| 108 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.69464031 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.69444180 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67842358 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66552626 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.64779119 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62563263 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.62220384 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62012664 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.61989761 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.61920458 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61165154 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60826680 |
| 120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60295719 |
| 121 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59440784 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59270428 |
| 123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58484727 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56260616 |
| 125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56072373 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55159238 |
| 127 | ABC transporters_Homo sapiens_hsa02010 | 0.54940025 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53001028 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47730417 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46107804 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46070507 |
| 132 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45836272 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45816377 |
| 134 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45720941 |
| 135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44873092 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44732861 |
| 137 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44411857 |
| 138 | Legionellosis_Homo sapiens_hsa05134 | 0.42970034 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42689898 |
| 140 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42435473 |
| 141 | Pertussis_Homo sapiens_hsa05133 | 0.41945156 |
| 142 | Morphine addiction_Homo sapiens_hsa05032 | 0.40483231 |
| 143 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40380951 |
| 144 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40343005 |
| 145 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38345224 |
| 146 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37491465 |
| 147 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37429983 |
| 148 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36878863 |
| 149 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36341795 |
| 150 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32917212 |
| 151 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31752865 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.31698093 |
| 153 | Salivary secretion_Homo sapiens_hsa04970 | 0.30241307 |
| 154 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30157680 |
| 155 | Insulin secretion_Homo sapiens_hsa04911 | 0.29040441 |
| 156 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28186816 |
| 157 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27832412 |
| 158 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26020993 |
| 159 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25890781 |
| 160 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25373195 |
| 161 | Lysosome_Homo sapiens_hsa04142 | 0.23032996 |
| 162 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20037831 |
| 163 | Purine metabolism_Homo sapiens_hsa00230 | 0.19072063 |
| 164 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.17289466 |
| 165 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15178290 |
| 166 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14905572 |
| 167 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.08596714 |
| 168 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.07417284 |
| 169 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.05058168 |
| 170 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.03858289 |
| 171 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02626807 |
| 172 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02409427 |

